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The surgical removal of petroclival meningiomas has historically been associated with a high incidence of morbidity 
and mortality. The 109 consecutive patients included in the present retrospective study represent a combined series of 
tumors operated on by the four authors during a period from 1980 to 1992. The series is composed of 40 men and 69 
women ranging in age from 25 to 75 years (mean 51 years). Surgical approaches to tumors in this series included simple 
retromastoid (60 cases), combined supra- and infratentorial petrosal (22), transtemporal (primary transsigmoid retro- 
labyrinthine, translabyrinthine, or transcochlear (12)), subtemporal (11), and frontotemporal transcavernous (eight). Gross- 
total removal was achieved in 75 patients (69%). Recurrence or progression of disease occurred in 14 patients (13%) over 
a 6.1-year mean follow-up period, and it was found within the cavernous sinus in 12 of these cases. Four recurrent cases 
demonstrated histological compatibility with malignant meningioma. Perioperative death occurred in four patients, and 
there were 56 significant complications in 35 other patients. Review of this series, with the attendant complications, has 
facilitated the authors’ decision-making when considering the risk of gross-total removal in selected patients with asymp­
tomatic cavernous sinus invasion or tumor adherent to the brainstem.
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C o n s id e r in g  their proximity to cranial nerves, the 
basilar artery and its perforating branches, and the 
brainstem, petroclival meningiomas are not statis­
tically frequent, but they represent some of the most for­
midable challenges in skull base surgery.1 These lesions 
may attain surprisingly large size with minimal symp­
toms; however, with continued growth in this location, 
their natural history is one of ultimate progression to fatal- 
ity.5’611’53 Prior to 1970, the risk of mortality from resection 
of petroclival meningiomas exceeded 50%.5-711'44'52'53 In­
deed, a successful total removal was reported in only one 
case prior to 1970,36 and as recently as 1967 these tumors 
were deemed by some authors to be “inoperable.”40 
Many clinical decisions regarding the extent of neces­
sary resection have been based on small series with limit­
ed follow-up periods.22’36’4449 The goals for resection of 
these tumors may vary among patients based on the par­
ticular location of the tumor and the age of the patient. For 
example, older patients with slow growing neoplasms 
may derive symptomatic relief with subtotal resection and 
careful postoperative follow up. In this regard, asymp­
tomatic cavernous sinus extension of tumor originating in 
the posterior fossa or in the region of Meckel’s cave 
represents a controversial indication for attempted total 
removal.
The present study reviews the combined experience of 
four surgeons, and proposes an individual approach to 
these tumors based on tumor size and associated region 
of local invasion as determined by both radiographic and 
clinical criteria. To this end, review of this series and com­
parison of extent of surgical resection with follow up data 
has provided information that has modified the authors’ 
management of some of these difficult lesions.
We are in agreement with other authors in considering 
lower-third clival-located tumors as being primarily fora­
men magnum lesions and as such they will not be dis­
cussed here;1 furthermore, using this strict definition we 
have not included the lateral petrous or petrotentorial le­
sions that have been included in other series,36 because 
tumors in these locations pose a much lower risk for cra­
nial nerve injury with their removal (Fig. 1).
C linical M a te ria l a n d  M ethods
Patient Population
The 109 consecutive cases represent a combined series 
of patients operated on by the four authors in a period 
from 1980 to 1992. These patients were operated on in 
three hospitals (Mitsui Memorial Hospital, Tokyo, Japan,
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Fig. 1. Illustrations showing definition of petroclival meningiomas in the present study. Tumors defined as petrocli­
val are those with basal attachments at or medial to the skull base foramina of cranial nerves V through IX, X, and XI. 
This area is demonstrated by the shaded region in the basal view (left). The upper and middle clival region includes the 
posterior clinoid processes, the dorsum sellae, and the clivus down to the jugular foramina. Lesions of the lower third of 
the clivus (medium shaded region of the lateral view, right) are best considered as foramen magnum in location when 
planning surgical strategies and will not be discussed here (from Couldwell and Weiss,9 with permission).
80 cases; University of Southern California University 
Hospital, Los Angeles, and the Los Angeles County/Uni­
versity of Southern California Medical Center, Los Ange­
les, California, 29 cases). All patients’ operative records, 
radiographs, and case histories with postoperative courses 
were reviewed for this retrospective study. The ages of 
patients in this series ranged from 25 to 75 years (mean 
51 years). The male/female ratio was 40:69. Presenting 
symptoms were related to cranial nerve impairment, cere­
bellar or brainstem compression, or increased intracranial 
pressure. The most common presenting symptoms in our 
series were gait disturbance or headache (90%), whereas 
cranial nerve palsies represented the most common pre­
senting signs. Symptoms such as motor deficit or gait dis­
turbance are often very slowly progressive and in many 
cases the diagnosis is delayed. Cranial neuropathies in­
cluded any within the posterior or middle fossa, with uni­
lateral hearing loss or facial sensory disturbances the most 
frequently encountered.
Neuroradiological Evaluation
All patients underwent preoperative unenhanced and 
enhanced computerized tomography (CT) or magnetic 
resonance (MR) imaging. All tumors carried the preoper­
ative radiological diagnosis of meningioma and were sig­
nificantly contrast enhancing. The preoperative sizes of 
the lesions are presented in Fig. 2; note that 80% of these 
lesions were greater than 2  cm in their largest dimension. 
Four-vessel cerebral angiography was performed only in 
those cases with expected engulfment and compromise of 
the basilar artery or one of its major branches, or in those 
cases with cavernous sinus extension and suspected carot­
id artery involvement.
Surgical Procedures
The surgical approaches used are listed in Table 1. The 
most common procedure was a simple retromastoid ap­
proach. However, more recently the combined supra- and 
infratentorial transpetrosal sinus (or simply “petrosal”) 
approach has been used, comprising 2 2  patients in the
total series but a larger percentage in the most recent peri­
od (10 of the last 22 large tumors). The primary trans­
temporal approaches included transsigmoid (one case), 
translabyrinthine (eight cases), and transcochlear (three 
cases). A primary subtemporal approach was used in 11 
patients, three of whom had previously undergone a retro- 
mastoid craniotomy for removal of the major posterior 
fossa component of the tumor. In four of these 11 patients, 
a posterior transcavernous dissection was performed for 
tumor present in Meckel’s cave and extending into the 
posterior cavernous sinus. A pterional frontotemporal ap­
proach was chosen for the remaining eight cases in the 
series.
Regardless of the approach chosen, patients received 
high-dose glucocorticoids intravenously (solumedrol 40 
mg q6 h or dexamethasone 1 0  mg q6 h), starting the day 
prior to surgery. Cranial nerve monitoring (brainstem au­
ditory evoked response), evoked potential, and electroen-
Medium (2-4 cm)
Tumor size
Fig. 2. Bar graph showing preoperative tumor size in this se­
ries of 109 patients. Histogram plots representing the number of 
patients presenting with small (< 2 cm), medium (2-4 cm), or 
large (>  4 cm) tumors. Note that the majority of tumors in this 
series presented greater than 2 cm in size (80%).
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TABLE 1
Surgical approaches used in the 109 patients with 
petroclival meningiomas*
Surgical Approach No. of Tumors
retromastoid/retrosigmoid 60
combined petrosal (with retrolabyrinthine, 22
translabyrinthine, or transcochlear temporal exposure)




* Note that four patients underwent staged procedures for tumor 
removal.
cephalographic monitoring were used in most cases in the 
series and in all surgical cases since 1987.
Evaluation of Treatment
The extent of removal was evaluated by intraoperative 
observation and postoperative enhanced CT or MR im­
aging obtained within 3 months of surgery. Gross-total 
removal was determined by intraoperative evidence of no 
remaining tumor together with no evidence of enhanc­
ing tumor on postoperative radiographic evaluation. Any 
other criteria were considered to be a subtotal resection.
R esults
Complete (gross-total) operative tumor removal was 
achieved in 75 (69%) of the 109 patients in this series. 
This was supported by complete intraoperative tumor 
resection with no evidence of tumor on postoperative CT 
and/or MR studies within 3 months of surgery. The 
remaining patients all had gross or microscopic residual 
tumor acknowledged to be remaining at the time of oper­
ative closure.
Clinical or radiographic evidence of recurrence (or pro­
gression in those patients with subtotal resection) occurred 
in 14 patients (13%) over a mean follow-up period of 6.1 
years (range 2.1-14 years). In four of these 14 patients, the 
histology was determined to be malignant at the initial 
surgery, and all of these patients had received postopera­
tive external-beam radiation therapy. The remainder of 
tumors operated on all had demonstrated benign histology 
at the initial resection.
Of the 34 patients with a subtotal tumor removal, 20 
patients had acknowledged gross tumor extending into the 
posterior cavernous sinus. Twelve of the 20 patients 
demonstrated radiographic progression of the tumor with­
in the remaining cavernous sinus component (comprising 
12 of the 14 total patients demonstrating progression or 
recurrence); six of these patients then underwent a course 
of external-beam radiation therapy, and the remaining six 
patients underwent a staged removal of the cavernous 
component, with oncological total removal of tumor and 
involved nerves, with carotid artery resection and saphe­
nous vein-carotid artery anastomosis. None of the 1 2  
patients with cavernous sinus progression has demonstrat­
ed recurrence in the subsequent follow-up period (mean 
4.4 years). Of the six patients who underwent surgical
TABLE 2
















vocal cord paralysis 2
* CN = cranial nerve.
resection, all had clinically documented progressive cra­
nial neuropathies (two patients had a complete cavernous 
sinus syndrome). The remaining eight patients with 
asymptomatic residual tumor within the cavernous sinus 
have demonstrated no radiographic or clinical progression 
during the follow-up period.
In the two remaining patients (of the 14 total) who 
demonstrated tumor recurrence or progression, one recur­
rent tumor was noted at the region of Dorello’s foramen 
18 months following removal of an upper clival tumor and 
the other in the inferior one-third of the clivus 2  years fol­
lowing resection of a midclival tumor. These were both 
resected without sequelae and the patients are currently 
recurrence free following the second surgery and postop­
erative radiation therapy.
Surgical Complications
The complications from surgery in this series are listed 
in Table 2. Death occurred in four patients (3.7%); all 
deaths were related to postoperative complications sec­
ondary to depressed neurological status (pulmonary em­
bolus in one patient and sepsis secondary to pneumonia in 
three patients). There were 56 significant permanent com­
plications in 35 additional patients. Major morbidity from 
significant brainstem infarction resulting in hemiparesis 
or gait instability occurred in 16 patients. Four patients 
developed postoperative hematomas, two of which re­
quired surgical removal and resulted in permanent neuro­
logical deficit. Permanent cranial nerve deficits occurred 
in 36 patients (33%); the most frequent were those involv­
ing the cavernous sinus (third, fourth, fifth, and sixth cra­
nial nerves). Five patients had complete sensorineuronal 
hearing loss resulting from surgery (excluding translaby- 
rinthine removal). Two patients developed true vocal cord 
paralysis with resulting aspiration, requiring temporary 
tracheostomy. Both of these patients were successfully 
decannulated with no permanent sequelae.
Illu s tra tiv e  Cases
Review of this series emphasizes two important clinical 
situations in which subtotal resection should be contem-
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Fig. 3. Case 1. Computerized tomography (CT) and magnetic resonance (MR) images showing associated cavernous 
sinus involvement. A 72-year-old man presented with a 3-year history of progressive gait ataxia, right leg paresis, and 
left-sided hearing loss. There was no evidence of clinical oculomotor paralysis or facial sensory loss. Note the large left 
petroclival tumor with obvious cavernous sinus involvement (A). Following a combined supra- and infratentorial petro­
sal approach, the tumor was resected from the posterior fossa, although the portion of the tumor entering Meckel’s cave 
was not removed. Postoperative CT (B) shows resection of the posterior fossa component with a fat graft placed in the 
temporal bone defect. Three-month postoperative MR images show residual tumor in the cavernous sinus (C) which 
remains unchanged over a 3-year follow-up period (D). Note the high-intensity fat graft remaining at the position of the 
apex of the petrous bone. The patient has demonstrated no clinical progression, with binocular vision.
plated given the potential morbidity involved with at­
tempting total removal.
Case 1: Associated Cavernous Sinus Involvement
This 72-year-old man presented with a 3-year history of 
progressive gait ataxia, right leg paresis, and left-sided 
hearing loss (Fig. 3). The symptoms had been insidious, 
and workup had included only a previous lumbar spine 
MR image to rule out nerve root compression. Neuro­
logical examination was remarkable for near-total sen- 
sorineuronal hearing loss in the left ear, mild left arm dys- 
metria, and mild paresis of the right leg with no associated 
sensory abnormalities. Preoperative CT revealed a large 
( 6  cm) broad-based lesion consistent with petroclival 
meningioma (Fig. 3A). The patient underwent a combined 
supra- and infratentorial (petrosal) approach, in combina­
tion with translabyrinthine temporal drilling, with resec­
tion of the posterior fossa mass. The tumor was noted to 
enter the cavernous sinus both on preoperative imaging 
and intraoperatively. Because the patient manifested no 
evidence of preoperative cranial nerve deficit from this 
cavernous involvement, a decision was made not to re­
move the intracavernous portion. The postoperative CT 
scans demonstrated removal of the posterior fossa compo­
nent of the tumor, with a residual tumor within the con­
fines of the cavernous sinus (Fig. 3B). The preoperative 
hemiparesis resolved. In a 3-year postoperative follow up, 
the patient showed no progression of cavernous sinus 
involvement either clinically or radiographically (Fig. 
3C and D).
Case 2: Tumor Capsular Adhesion to Brainstem
This 57-year-old woman presented with an insidious 
history of progressive headaches and gait ataxia (Fig. 4). 
Clinical examination was remarkable for right-sided ap­
pendicular ataxia. With the exception of mild sensorineu- 
ronal hearing loss, there were no cranial nerve abnormal­
ities. A preoperative MR image revealed a large gadolini­
um-enhancing petroclival tumor with marked brainstem 
compromise (Fig. 4A). The patient underwent a combined 
supra- and infratentorial (petrosal) approach; at surgery, 
the bulk of the tumor was removed without difficulty, 
although the medial margin of the tumor was noted to be 
very adherent to the brainstem. Because of this adherence, 
an intraoperative decision was made to abort the dissec­
tion from the brainstem and leave the adherent capsule. 
Scanning immediately after surgery (Fig. 4B) and 2 years 
later (Fig. 4C) showed no growth of the remaining cap­
sule. With the exception of deafness in the ipsilateral ear, 
the patient had an uneventful postoperative course with 
return to complete activity.
D iscussion
Classification Schemes
Posterior fossa meningiomas constitute some 10% of 
all intracranial meningiomas.1,2,5,6 Classifications of poste­
rior fossa tumors have been put forth by Castellano and 
Ruggiero6 and Yasargil, et al.53 Using postmortem studies, 
Castellano and Ruggiero classified posterior fossa tumors 
by site of dural attachment. They described their location 
as either cerebellar convexity (10%), tentorium (30%), 
posterior petrous (42%), clivus (11%), or foramen mag­
num (4%). They also noted a group of tumors that extend­
ed from Meckel’s cave into the posterior fossa. Yasargil, 
et al., classified posterior fossa tumors based on intraop­
erative observations into those with primary attachment to 
clival, petroclival, sphenopetroclival, foramen magnum, 
or cerebellopontine angle locations.
Unfortunately, these classification schemes do not dif­
ferentiate the clinically recognized petroclival location ex­
clusively from other tumor locations. Petroclival menin­
giomas represent only a percentage of meningiomas 
that reside in the posterior fossa. Tumors emanating at or
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Fig. 4. Case 2. Magnetic resonance (MR) imaging and computerized tomography (CT) demonstrating tumor adher­
ence to the brainstem in a 57-year-old woman with gait ataxia and headaches. Preoperative examination revealed mild 
sensorineural hearing loss and appendicular ataxia. The large right petroclival tumor (A) was resected via a petrosal 
approach. At surgery, it was noted that the medial tumor capsule was densely adherent to the brainstem, and a decision 
was made to leave a small margin of tumor. Comparison of the immediate postoperative CT scan (B) and the follow-up 
MR study 2 years later (C) demonstrates no evidence of progression. With the exception of complete ipsilateral sen- 
sorineuronal hearing loss, the patient is neurologically intact.
medial to the entrance or exit of cranial nerves at the base 
of the skull are those that should be strictly classified as 
within the petroclival area. These tumors present a surgi­
cal challenge: cranial nerves are interposed between the 
surgeon and the pathology, and the tumor often displaces 
or engulfs the basilar artery or its major branches and the 
perforating vasculature supplying the brainstem. The one 
exception in classifying these lesions by this method is 
the tumor that commonly emanates directly from the re­
gion of Meckel’s cave, to which Cushing and Eisenhardt10 
ascribed the name “gassero-petrosal” (equivalent to the 
sphenopetroclival tumors of Yas argil53). With continued 
growth, such tumors invariably become both supra- and 
infratentorial, and occupy both medial and lateral posi­
tions to the fifth nerve. From a clinical perspective, these 
tumors are to be considered together with those originat­
ing medial to Meckel’s cave (either apical petroclival or 
pure clival), as surgical strategies for their attack will be 
similar. They are considered by most authors to be includ­
ed in the petroclival classification.
Thus, the strict definition of petroclival tumors in the 
present series is suggested (Fig. 1), with particular atten­
tion being paid to the location of dural attachment in re­
lation to the foramina of specific cranial nerves,9 critical 
when determining the difficulties inherent in surgical 
resection. As noted in Fig. 1, tumors emanating from the 
lower third of the clivus at or medial to the hypoglossal 
canal are best considered as foramen magnum in location.
Surgical Morbidity and Mortality
Because of their location, the surgical removal of petro- 
clival meningiomas has historically been associated with 
high morbidity and mortality.5,611’22’23 With the advent of 
improved microsurgical technique, removal of these tu­
mors has become increasingly safe, with more recently 
published series demonstrating less than 1 0 % mortali­
ty. l’4’22’43’44’48’49 The surgical results of the present study 
are in agreement with such contemporary studies. The 
3.7% mortality in the present series compares favorably to 
the 9 % mortality reported in a series of 3 5  patients by
Mayberg and Symon,36 and the 17% and 15% mortality 
reported by Hakuba, et al.,22 and Yasargil, et al.,53 respec­
tively, all of which were reported after the development 
of microsurgical techniques. The present series’ mortality 
is also consistent with the absence of deaths reported in 
the more recent smaller series of Al-Mefty, et al.,1 and 
Samii, et al.44
These tumors, however, remain a surgical challenge 
because of the relatively high incidence of permanent 
complications associated with their removal. In the pres­
ent series, 35 (33%) of 105 patients developed a total of 
56 permanent complications (Table 2). This figure com­
pares favorably with the 53% complication rate reported 
in series prior to 1970;53 the 50% incidence of permanent 
postoperative deficits reported by Mayberg and Symon;36 
and the recently published experience of Bricolo, et al.4 
However, it is only marginally improved over the 46% 
permanent complication rate reported in the series of 
Samii, et al.,44 although it is consistent with the 4 of 13 
patients who demonstrated new permanent postoperative 
deficits in the series of Al-Mefty, et al.1
Not surprisingly, cranial neuropathies were the most 
frequent complication encountered; the nerves most often 
involved were those associated with cavernous sinus 
tumor and its removal (third, fourth, fifth, and sixth cranial 
nerves). Consistent with previous experience, the size 
of the lesion was of significance in determining surgical 
morbidity and mortality.4,43,45
Recurrence Rate
The recurrence rate in the present series is low over the 
defined follow-up period, with 13% of patients having 
documented recurrence or progression (radiographic or 
clinical) over a mean follow-up period of 6.1 years. Four 
of these 14 patients demonstrated malignant tumor histol­
ogy at the time of the initial resection. The low rate of 
recurrence for the benign tumors in this series corresponds 
to those reported in earlier smaller series: of 35 patients 
reported by Mayberg and Symon,36 progression occurred 
in only 15% of 30 cases followed for a mean of 34
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TABLE 3
Choice o f surgical approaches to remove petroclival meningiomas*
Surgical Approach Factors Indicating Approach
retromastoid/retrosigmoid small- or medium-sized tumors 
limited dural attachment 
mid or upper clivus
small- or medium-sized tumors 
medial or lateral location 
nonfunctional hearing status 
(transcochlear or translabyrinthine only)
large tumor
extensive basal attachment 
supra- and infratentorial
small- or medium-sized tumors 
majority of tumor volume above tentorium 
may be combined with posterior transcav- 
ernous exploration
* Factors considered in the choice of surgical approaches used in the 
present series. The decision regarding the approach was based on tumor 
size and site of dural attachment. A more limited approach was necessary 
if a subtotal resection was planned.
months. Furthermore, Sekhar and Samii49 noted that only 
one (2 0 %) of five patients known to harbor residual tumor 
experienced progression, and Samii, et al. ,44 noted no 
recurrence in 24 patients operated on over a 2-year period. 
Twelve of the 14 patients in the present series developed 
tumor progression from residual gross tumor within the 
cavernous sinus, which emphasizes the importance of this 
location as a likely site for recurrence in tumors straddling 
the petrous apex.
Surgical Approaches
An excellent review of potential approaches to petrocli- 
val meningiomas has been recently published2 and in­
cludes frontotemporal,53 subtemporal-transtentorial,3,38,41 
occipital-transtentorial,51 suboccipital (that is, retromas-
toid) ,10,35,42,49 combined subtemporal and translabyrin- 
thine,28,37 combined suboccipital and translabyrinthine,24 
and transcochlear25 and transtemporal19’46 approaches. 
Other more extensive or less commonly reported ap­
proaches to the intradural clival region include the extend­
ed transbasal,12 midline approaches (transsphenoidal, 
transoral, transcervical) ,12 infratemporal, 15,16 and facial 
translocation (degloving) .26
In planning an approach to a meningioma in this region 
the most important factors considered by the authors were 
the location and extent of skull base attachment (Table 3). 
Examination of the preoperative gadolinium-enhanced 
MR images provides the most valuable information re­
garding skull base attachment and/or involvement by the 
tumor. In addition, with the use of high-field thin-section 
MR imaging many cranial nerves can be visualized in 
their intradural course and any deviation or loss of conti­
nuity within the tumor mass is carefully noted. In cases of 
sizable lesions whose entire mass was within the posteri­
or fossa, suboccipital and/or transtemporal bone removal 
was performed; extension beyond the tentorial hiatus 
required additional supratentorial exposure if total re­
moval was attempted. This was accomplished either by 
direct supratentorial transsylvian or subtemporal exposure
or by opening the tentorium via the posterior fossa. With 
midline tumors entirely related to the clivus, a more later­
al-basal approach was chosen to visualize the attachment. 
Ideally, an approach was chosen to expose and enable 
immediate interruption of the tumor blood supply at the 
base of the skull; this may be accomplished intra- or ex­
tradurally, depending on the location of the attachment. 
Midline approaches through contaminated fields were 
avoided; this was for reasons of both the inherent risk of 
meningitis from operating in a contaminated field and the 
difficulty in obtaining an adequate dural closure following 
resection.
Another major consideration in approaching the tumors 
in this series was the status of the patient’s hearing. The 
acoustic nerve is prone to early injury from tumor growth, 
so hearing is often already diminished. If preoperative 
hearing assessment indicated functional hearing was sig­
nificantly impaired (>  50 dB hearing loss or <  50% 
speech discrimination), a translabyrinthine or transco- 
chlear exposure, which sacrificed remaining hearing, was 
considered to facilitate more medial exposure to the tumor 
attachment while providing early interruption of the tumor 
blood supply through removal of the temporal bone.
The surgical approaches used in the present series indi­
cate the combined preferences of the four authors. The 
most popular approach was the simple retromastoid (ret- 
rosigmoid) craniotomy; this approach was used for small­
er tumors that were medially or laterally situated, with a 
limited area of dural attachment, and in patients with 
intact hearing. In tumors with more extensive basal attach­
ment and in tumors operated on more recently in this 
series, the combined supra- and infratentorial parapetro- 
sal (or simply petrosal) approach was utilized with in­
creasing frequency.8’17’18’32’34’50 This approach has had a 
lengthy evolution217 and has been recently popularized 
and refined by Malis,33,34 Al-Mefty, et al. , 1 Kawase, et 
al.,11 Spetzler, et al.,50 and our group.818 In the present 
series, the approach was used for tumors centered about 
the petrous apex and in large-sized lesions with significant 
supra- and infratentorial extension. The mastoid removal 
may be combined with any of the standard transtemporal 
exposures, depending on the status of hearing or the extent 
of bone removal desired. The approach has virtually elim­
inated staging tumor removal due to anatomical limita­
tions. Primary transtemporal approaches (defined here 
to include presigmoid or transsigmoid retrolabyrinthine, 
translabyrinthine, and transcochlear) were chosen for a 
minority of tumors in this series (12 cases). Temporal 
bone drilling was used in those tumors with a more exten­
sive medial-lateral attachment, with minimal supratento- 
rial extension. The obvious disadvantage relates to hear­
ing loss following drilling of the labyrinth or cochlea; in 
addition, the dural opening may be limited, but these 
approaches may be combined with a standard retromas- 
toid craniotomy if the sigmoid sinus is sacrificed.50 A pri­
mary subtemporal (supratentorial craniotomy) approach 
was performed in 11 patients in the present series, three of 
whom had previously undergone a retromastoid cranioto­
my for removal of the major posterior fossa component of 
the tumor. In primary removals, the approach was chosen 
in those instances in which most of the tumor was located 
supratentorially. In four of these 11 patients, a posterior 
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Fig. 5. Current general guidelines used by the authors as goals 
of surgical resection based on the age of the patient, size of tumor, 
and presenting symptomatology. (CN = clinical cavernous cranial 
nerve involvement.) In young patients aggressive removal is al­
ways undertaken except in situations in which the cavernous sinus 
is radiographically involved without cranial neuropathies. How­
ever, in elderly individuals a much less aggressive approach is 
taken, and the authors perform resections in symptomatic cases 
only. Large tumors involving the cavernous sinus are subtotally 
resected if cranial nerve function is intact, removing only the major 
compressive component. The information listed is general, and the 
individual situation and surgical judgement always prevail in final 
case management.
ent in Meckel’s cave and extending anterior into the pos­
terior cavernous sinus.23 The authors have reserved the use 
of this posterior transcavernous approach for those cases 
in which removal of the posterior cavernous tumor com­
ponent is a fundamental goal and in which the major 
tumor volume presents above the level of the mid-to- 
upper clivus. A frontotemporal approach was used in only 
eight patients in the present series; it was chosen in those 
cases in which the majority of the tumor was located 
supratentorially and involved the cavernous sinus and in 
which a preoperative decision was made to resect the cav­
ernous component. Depending on the superior extent of 
the tumor above the dorsum sellae, an orbitozygomatic 
(or pure zygomatic) osteotomy was performed with this 
approach, ultimately to enable a lower visual trajectory to 
facilitate viewing of tumors projecting superiorly.
Goals of Surgical Resection
Review of this series has offered some insights that 
have modified the authors’ present approach to the treat­
ment of these lesions. When defining the goals of surgery 
in the management of these tumors, it is important to con­
sider the age of the patient, the location of the tumor, and 
the presenting symptomatology (Fig. 5).
A general tenet practiced by the authors is that whenev­
er possible aggressive surgical removal should be the 
goal; this prevails as the best hope for a cure or extend­
ed tumor control.2 Exceptions to this rule arise if the risk 
of increasing neurological deficit is prohibitive.39 Spe­
cifically, there are some intraoperative conditions that 
may preempt total removal, including the liability for sig­
nificant morbidity from tumor involvement of cranial 
nerves or brainstem vasculature. Many of the final deci­
sions regarding the amount of removal are made intraop- 
eratively, based on the surgeon’s judgment of risk in­
volved with resection.
1) Cavernous Sinus Involvement. Because of the com­
mon source of origin of many of these tumors involving 
Meckel’s cave, often there is cavernous sinus involvement 
that can be seen radiographically, with little or no cav­
ernous cranial neuropathy. Mere radiographic cavernous 
sinus extension of tumor presently represents a controver­
sial indication for attempted total removal;13 it is our pres­
ent practice to limit removal or exploration of this region 
if the patient has functional binocular vision (that is, no 
significant diplopia) and facial sensation that is not signif­
icantly impaired. Thus, in such patients a staged approach 
is planned, with observation of the intracavernous compo­
nent or possible adjuvant radiation or radiosurgical treat­
ment until such time as the patient develops evidence of 
progressive cranial neuropathies from tumor growth. In 
the present series, 1 2  (60%) of 2 0  patients with gross 
tumor remaining in this location showed progression ra- 
diographically and clinically over the follow-up period; it 
was at this juncture that consideration was given to a rad­
ical intracavernous exploration and removal. In a young­
er patient, this may require an aggressive approach with 
radical cavernous sinus resection, including the cavern­
ous portion of the carotid artery if involved with tumor. 
The antiprogesterone agent RU 48621,30,31 and radiosur­
gery14,29,32 may offer alternative treatments for the intra- 
cavernous component, pending the long-term follow-up 
results of current ongoing trials.
2) Patient Age. In elderly patients, especially in those 
with associated medical problems, the goals of surgery 
must be limited appropriately. In selected cases, subtotal 
removal or staged procedures may be considered, such as 
in patients with minimal or no cranial nerve symptoms but 
with significant brainstem compression. In these individ­
uals a subtotal procedure designed to debulk the compres­
sive mass of the tumor may be justified, with no attempt 
to remove that part of the tumor invading the cavernous 
sinus or adherent to the brainstem. As demonstrated by 
the patient in Case 1 (Fig. 3), these patients may be fol­
lowed for years with little evidence of progression of cra­
nial nerve compromise despite gross cavernous invasion. 
Because many of the tumors in this location are slow 
growing, asymptomatic lesions in elderly patients clearly 
warrant an observation period before attempting surgical 
removal.
3) Vascular Involvement and Pial Invasion of the Brain­
stem. Additional difficulty arises when a tumor encases 
the basilar artery,47 lies between the artery and brainstem, 
or parasitizes the microvascular supply to the brainstem. 
In such instances extreme care must be exercised in 
removing this tumor, because interruption of perforating 
vasculature may result in grievous brainstem infarction. 
However, as noted by Sekhar and Javed,47 an arachnoidal 
plane surrounding a blood vessel allows it to be dissected 
free by experienced surgeons in the majority of cases. 
Tumor adherence to the brainstem may be anticipated in 
some cases on preoperative MR imaging; some authors 
have reported such parameters as loss of arachnoidal plane 
on T1- and T2-weighted images, and edema of the brain-
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stem seen best on T2 images as indicators of pial inva- 
sion.45 An intraoperative decision must be made to ascer­
tain whether removal of the tumor in this location is justi­
fied; in those cases in which removal is difficult or the 
tumor is adherent to vascular structures a more conserva­
tive approach is advocated. As illustrated in Fig. 4, in 
these cases we do not hesitate to leave a thin portion (<  4 
mm) of capsule adherent to these structures.
Adjuvant Radiation Therapy
Several retrospective studies have documented the effi­
cacy of radiation therapy following surgery for subtotally 
resected meningiomas (recently reviewed by Goldsmith, 
et al.20) Moreover, the advent of focused radiosurgical 
techniques has enabled delivery of radiation doses with 
a steep fall off to limit radiation to nontumor locations. 
Meningiomas, characterized by well-defined radiographic 
margins, no brain invasion in benign cases, and vascular­
ity that may be obliterated with radiation therapy, are par­
ticularly well-suited to delivery of this type of therapy.1429 
Little published data with significant follow-up periods 
exist for cranial base meningiomas, but initial reports by 
Lunsford32 suggest that greater than 90% 4-year actuarial 
tumor control rates may be achieved with gamma knife 
therapy of skull base meningiomas. Specifically with 
tumors involving the cavernous sinus, they noted a low 
6 % incidence of delayed cranial nerve compromise; if this 
experience is substantiated in ongoing trials, then this 
therapy should become a regular adjuvant to the overall 
management, decreasing recurrence rates in subtotally 
resected lesions. Although patients in the present series 
did not undergo routine radiosurgical treatment of residual 
tumor for reasons of limited availability during most of 
the era, our current practice is to offer this option to this 
select group of patients.
C onclusions
The review of the present large series of patients has 
illustrated that the surgical removal of petroclival menin­
giomas still presents a surgical challenge. Although mor­
tality in the present and other contemporary series has 
been dramatically reduced, surgical morbidity remains 
significant, largely from associated cranial neuropathies. 
The appropriate management strategy should be based on 
the age of the patient and presenting clinical symptoms, 
radiographic definition of the lesion, and goals of surgical 
resection for that particular individual. Although it is 
appropriate to strive for total removal of all tumors, in 
specific instances subtotal resection may be indicated. 
Overall recurrence rates remain low, but the present re­
view has identified the cavernous sinus as a likely region 
for recurrence or progression of subtotally resected 
lesions. It is in this group of patients that adjuvant thera­
py, such as radiosurgery, may be indicated to prevent or 
delay cavernous cranial neuropathies from tumor recur­
rence. The surgeon must remain cognizant of the frequen­
cy with which patients presenting with minimal symptoms 
may be functionally impaired postoperatively, while at­
tempting a potential “curative” operation; we are in agree­
ment with other authors in that avoidance of surgically 
induced neurological deficit remains a primary considera- 
tion. 13,39
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